Provided by Tiger Trade Technology Pte. Ltd.

LeMaitre Vascular

106.59
-3.7400-3.39%
Volume:222.06K
Turnover:23.80M
Market Cap:2.42B
PE:42.30
High:109.68
Open:109.31
Low:104.14
Close:110.33
52wk High:115.33
52wk Low:71.42
Shares:22.69M
Float Shares:20.80M
Volume Ratio:0.71
T/O Rate:1.07%
Dividend:0.80
Dividend Rate:0.75%
EPS(TTM):2.52
EPS(LYR):2.52
ROE:15.80%
ROA:6.76%
PB:6.14
PE(LYR):42.30

Loading ...

LeMaitre Vascular Outlook FY EPS $2.81 - $3.01

THOMSON REUTERS
·
Feb 26

LeMaitre Vascular Inc - Announces 25% Increase in Quarterly Dividend to $0.25/Share

THOMSON REUTERS
·
Feb 26

LeMaitre Vascular Q4 Pretax Profit USD 20.3 Million

THOMSON REUTERS
·
Feb 26

LeMaitre Vascular Outlook Q1 EPS USD 0.64-0.69

THOMSON REUTERS
·
Feb 26

LeMaitre Vascular Outlook Q1 Sales USD 65.6-67.6 Million

THOMSON REUTERS
·
Feb 26

LeMaitre Q4 2025 Financial Results

THOMSON REUTERS
·
Feb 26

LeMaitre Vascular Is Maintained at Outperform by Barrington Research

Dow Jones
·
Feb 20

Analysts Are Bullish on Top Healthcare Stocks: Lemaitre Vascular (LMAT), Guardant Health (GH)

TIPRANKS
·
Feb 20

Earning Preview: LeMaitre Vascular Q4 revenue is expected to increase by 12.56%, and institutional views are limited

Earnings Agent
·
Feb 18

Is LeMaitre Vascular (LMAT) Pricing Too Rich After Mixed Long Term Returns?

Simply Wall St.
·
Feb 18

LeMaitre Vascular Inc. to Release Fourth Quarter Financial Results

Reuters
·
Feb 11

Here's Why LeMaitre Vascular (NASDAQ:LMAT) Has Caught The Eye Of Investors

Simply Wall St.
·
Feb 06

Wells Fargo Remains a Hold on Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 26, 2025

LeMaitre Vascular Q3 Sales USD 61.046 Million Vs. IBES Estimate USD 62.2 Million

Reuters
·
Nov 20, 2025

LeMaitre Vascular’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 08, 2025

LeMaitre Vascular Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Nov 08, 2025

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), Lemaitre Vascular (LMAT) and Shattuck Labs (STTK)

TIPRANKS
·
Nov 08, 2025

LeMaitre Vascular’s Strong Financial Performance and Growth Prospects Justify Buy Rating and OUTPERFORM Status

TIPRANKS
·
Nov 08, 2025

Lake Street Sticks to Their Buy Rating for Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 08, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), MBX Biosciences, Inc. (MBX) and Lemaitre Vascular (LMAT)

TIPRANKS
·
Nov 07, 2025